skip to main content

Venous Thromboembolism in Cancer — MRCP Part 1 MCQ

Instant feedback + full explanation. One question, done properly.

HardE)."Venous Thromboembolism in Cancermrcp part 1

An adult with a new DVT is suitable for apixaban and has no dose-limiting interaction or organ impairment. What initial regimen is licensed?

Educational content. Not a substitute for clinical judgement or local policy.

Venous Thromboembolism in Cancer — MRCP Part 1 MCQ | iatroX